Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease

Movement Disorders

Volumn 22, Issue 1, 2007, Pages 107-111

  Lloret, Santiago Perez ^a   Arce, Gabriel Pirán ^a   Rossi, Malco ^a   Nemet, María Laura Caivano ^a   Salsamendi, Paz ^a   Merello, Marcelo ^a,b  

^a Instituto de Investigaciones Neurologicas Raul Carrera   (Argentina)

^b FLENI   (Argentina)

Author keywords

Clinical scale; Parkinson's disease; Sialorrhea

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRONBACH ALPHA COEFFICIENT; FEMALE; HUMAN; HYPERSALIVATION; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; SALIVA; SCORING SYSTEM; UNIFIED PARKINSON DISEASE RATING SCALE; VALIDATION PROCESS; VALIDITY;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SALIVA; SEVERITY OF ILLNESS INDEX; SIALORRHEA; STATISTICS AS TOPIC;

EID: 33847719451     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21152     Document Type: Article

References (29)

1. Adler CH. Nonmotor complications in Parkinson's disease. Mov Disord 2005;20(Suppl. 11):S23-S29.
2. Jost WH. Gastrointestinal motility problems in patients with Parkinson's disease. Effects of antiparkinsonian treatment and guidelines for management. Drugs Aging 1997;10:249-258.
3. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Clin Neurosci 1998;5:136-146.
4. Edwards LL, Quigley EM, Harned RK, Hofman R, Pfeiffer RF. Characterization of swallowing and defecation in Parkinson's disease. Am J Gastroenterol 1994;89:15-25.
5. Castell JA, Johnston BT, Colcher A, Li Q, Gideon RM, Castell DO. Manometric abnormalities of the oesophagus in patients with Parkinson's disease. Neurogastroenterol Motil 2001;13:361-364.
6. Hyson HC, Johnson AM, Jog MS. Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study. Mov Disord 2002;17:1318-1320.
7. Volonte MA, Porta M, Comi G. Clinical assessment of dysphagia in early phases of Parkinson's disease. Neurol Sci 2002;23(Suppl. 2):S121-S122.
8. Proulx M, de Courval FP, Wiseman MA, Panisset M. Salivary production in Parkinson's disease. Mov Disord 2005;20:204-207.
9. Bagheri H, Damase-Michel C, Lapeyre-Mestre M, et al. A study of salivary secretion in Parkinson's disease. Clin Neuropharmacol 1999;22:213-215.
10. Pazo JH, Belforte JE. Basal ganglia and functions of the autonomic nervous system. Cell Mol Neurobiol 2002;22:645-654.
11. White KD. Salivation: a review and experimental investigation of major techniques. Psychophysiology 1977;14:203-212.
12. Jones JM, Watkins CA, Hand JS, Warren JJ, Cowen HJ. Comparison of three salivary flow rate assessment methods in an elderly population. Community Dent Oral Epidemiol 2000;28:177-184.
13. Jongerius PH, van Limbeek J, Rotteveel JJ. Assessment of salivary flow rate: biologic variation and measure error. Laryngoscope 2004;114:1801-1804.
14. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
15. Takayanagi A, Nomura T, Yamanaka S, Takaesu Y. A modified device for long term sampling of parotid saliva in various experimental conditions. Bull Tokyo Dent Coll 1995;36:69-73.
16. Ghezzi EM, Lange LA, Ship JA. Determination of variation of stimulated salivary flow rates. J Dent Res 2000;79:1874-1878.
17. Percival RS, Challacombe SJ, Marsh PD. Flow rates of resting whole and stimulated parotid saliva in relation to age and gender. J Dent Res 1994;73:1416-1420.
18. Katayama S. Actigraph analysis of diurnal motor fluctuations during dopamine agonist therapy. Eur Neurol 2001;46(Suppl. 1):11-17.
19. van Hilten JJ, Middelkoop HA, Kerkhof GA, Roos RA. A new approach in the assessment of motor activity in Parkinson's disease. J Neurol Neurosurg Psychiatry 1991;54:976-979.
20. Patel PS, Ghezzi EM, Ship JA. Xerostomic complaints induced by an anti-sialogogue in healthy young vs. older adults. Spec Care Dentist 2001;21:176-181.
21. Chavez EM, Borrell LN, Taylor GW, Ship JA. A longitudinal analysis of salivary flow in control subjects and older adults with type 2 diabetes. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:166-173.
22. Brodtkorb E, Wyzocka-Bakowska MM, Lillevold PE, Sandvik L, Saunte C, Hestnes A. Transdermal scopolamine in drooling. J Ment Defic Res 1988;32(Pt 3):233-237.
23. Camp-Bruno JA, Winsberg BG, Green-Parsons AR, Abrams JP. Efficacy of benztropine therapy for drooling. Dev Med Child Neurol 1989;31:309-319.
24. Tscheng DZ. Sialorrhea - therapeutic drug options. Ann Pharmacother 2002;36:1785-1790.
25. Mancini F, Zangaglia R, Cristina S, et al. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord 2003;18:685-688.
26. Bhatia KP, Munchau A, Brown P. Botulinum toxin is a useful treatment in excessive drooling in saliva. J Neurol Neurosurg Psychiatry 1999;67:697.
27. Goode RL, Smith RA. The surgical management of sialorrhea. Laryngoscope 1970;80:1078-1089.
28. Racette BA, Good L, Sagitto S, Perlmutter JS. Botulinum toxin B reduces sialorrhea in parkinsonism. Mov Disord 2003;18:1059-1061.
29. Jongerius PH, Joosten F, Hoogen FJ, Gabreels FJ, Rotteveel JJ. The treatment of drooling by ultrasound-guided intraglandular injections of botulinum toxin type A into the salivary glands. Laryngoscope 2003;113:107-111.